Atlas Trials

Masonic Cancer Center, University of Minnesota

285 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Masonic Cancer Center, University of Minnesota

RecordFirmDate
Reduced Intensity AlloTransplant For Osteopetrosis (NCT00638820)Masonic Cancer Center, University of Minnesota2007-09-01
Empowering Cancer Survivors Through Information Technology (NCT01593618)Masonic Cancer Center, University of Minnesota2007-08-01
Deferasirox in Treating Patients With Iron Overload After Undergoing a Donor Stem Cell Transplant (NCT00602446)Masonic Cancer Center, University of Minnesota2007-08-01
Stem Cell Transplant (SCT) for Dyskeratosis Congenita or SAA (NCT00455312)Masonic Cancer Center, University of Minnesota2007-08-01
T-Regulatory Cell Infusion Post Umbilical Cord Blood Transplant in Patients With Advanced Hematologic Cancer (NCT00602693)Masonic Cancer Center, University of Minnesota2007-07-23
Fulvestrant in Treating Patients With Recurrent Ovarian Epithelial Cancer (NCT00617188)Masonic Cancer Center, University of Minnesota2007-06-01
Umbilical Cord Blood T-Regulatory Cell Infusion Followed by Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Leukemia or Other Hematologic Diseases (NCT00376519)Masonic Cancer Center, University of Minnesota2007-05-01
Allogeneic Hematopoietic Stem Cell Transplant For Epidermolysis Bullosa (NCT00478244)Masonic Cancer Center, University of Minnesota2007-04-01
Clinical Trial of Trametes Versicolor in Women With Breast Cancer (NCT00680667)Masonic Cancer Center, University of Minnesota2007-04-01
Carboplatin and Gemcitabine With Bevacizumab Every 2 Weeks for Stage IIIb/IV Non-small Cell Lung Cancer (NCT00400803)Masonic Cancer Center, University of Minnesota2007-03-01
Bortezomib and Gemcitabine in Treating Older Patients With Advanced Solid Tumors (NCT00620295)Masonic Cancer Center, University of Minnesota2007-03-01
Reduced Intensity Hematopoietic Cell Transplantation for Patients With Resistant Langerhans Cell Histiocytosis (NCT00618540)Masonic Cancer Center, University of Minnesota2007-01-01
Erlotinib, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB-Stage IVA Cervical Cancer (NCT00428194)Masonic Cancer Center, University of Minnesota2007-01-01
Fondaparinux in Preventing Blood Clots in Patients Undergoing Surgery for Gynecologic Cancer (NCT00381888)Masonic Cancer Center, University of Minnesota2007-01-01
Autologous Peripheral Blood Stem Cell Transplant for Germ Cell Tumors (NCT00432094)Masonic Cancer Center, University of Minnesota2006-12-19
HSCT for High Risk Inherited Inborn Errors (NCT00383448)Masonic Cancer Center, University of Minnesota2006-09-01
Topotecan and Bevacizumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Did Not Respond to Previous Systemic Chemotherapy (NCT00365547)Masonic Cancer Center, University of Minnesota2006-09-01
Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia (NCT00630565)Masonic Cancer Center, University of Minnesota2006-07-26
CerviPrep for Applying Topical Gemcitabine to the Cervix in Treating Patients With Primary Endometrial, Cervical, or Ovarian Epithelial Cancer (NCT00610740)Masonic Cancer Center, University of Minnesota2006-07-01
Phase II of Naltrexone in Hormone-Refractory Metastatic Breast Cancer (NCT00379197)Masonic Cancer Center, University of Minnesota2006-07-01
TBI Dose De-escalation for Fanconi Anemia (NCT00352976)Masonic Cancer Center, University of Minnesota2006-05-18
PET CT as Predictor of Response in Preoperative Chemotherapy for Soft Tissue Sarcoma (NCT00346125)Masonic Cancer Center, University of Minnesota2006-04-10
Allogeneic Natural Killer (NK) Cells in Patients With Advanced Metastatic Breast Cancer (NCT00376805)Masonic Cancer Center, University of Minnesota2006-04-01
Oxaliplatin, Docetaxel, and Radiation Therapy in Treating Patients With Unresectable Stage II/III or Recurrent NSCLC (NCT00356941)Masonic Cancer Center, University of Minnesota2006-04-01
Study of Immune Response Modifier in the Treatment of Breast, Ovarian, Endometrial and Cervical Cancers (NCT00319748)Masonic Cancer Center, University of Minnesota2006-04-01
Combination Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer (NCT00352118)Masonic Cancer Center, University of Minnesota2006-03-01
Donor Umbilical Cord Blood Natural Killer Cells, Aldesleukin and Umbilical Cord Blood Transplant in Patients With Refractory Hematologic Cancers. (NCT00354172)Masonic Cancer Center, University of Minnesota2006-02-01
Study of Immune Response Modifier in the Treatment of Hematologic Malignancies (NCT00276159)Masonic Cancer Center, University of Minnesota2006-01-01
Bortezomib and Cetuximab in Treating Patients With Advanced Solid Tumors (NCT00622674)Masonic Cancer Center, University of Minnesota2005-11-01
Hematopoietic Stem Cell Transplantation in the Treatment of Infant Leukemia (NCT00357565)Masonic Cancer Center, University of Minnesota2005-11-01
Carboplatin, Paclitaxel, and Surgery in Treating Patients With Advanced Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer (NCT00331422)Masonic Cancer Center, University of Minnesota2005-10-01
Autologous Peripheral Stem Cell Transplant in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Lymphoma (NCT00345865)Masonic Cancer Center, University of Minnesota2005-08-24
MT2004-30: Tomotherapy for Solid Tumors (NCT00623077)Masonic Cancer Center, University of Minnesota2005-08-01
Myeloablative Umbilical Cord Blood Transplantation in Hematological Diseases (NCT00309842)Masonic Cancer Center, University of Minnesota2005-07-28
Donor Stem Cell Transplant in Treating Patients With Myeloid Cancer or Other Disease (NCT00392782)Masonic Cancer Center, University of Minnesota2005-07-01
Carboplatin, Docetaxel, and Radiation Therapy in Treating Patients With Stage III/IV, or Recurrent Endometrial Cancer (NCT00258362)Masonic Cancer Center, University of Minnesota2005-07-01
Yttrium Y 90 Anti-CD45 Monoclonal Antibody AHN-12 in Treating Patients With Advanced Leukemia (NCT00618696)Masonic Cancer Center, University of Minnesota2005-07-01
Donor Umbilical Cord Blood Transplant By Injection Into the Bone Marrow in Treating Patients With Hematologic Cancer (NCT00295880)Masonic Cancer Center, University of Minnesota2005-06-01
Non-Myeloablative Conditioning for Unrelated Donor Umbilical Cord Blood Transplant (NCT00305682)Masonic Cancer Center, University of Minnesota2005-06-01
Outcomes in Ovarian Cancer and Fallopian Tube Cancer Patients Using Complementary Alternative Medicine (NCT00293293)Masonic Cancer Center, University of Minnesota2005-05-01
MRI in Predicting Tumor Reponse After Radiofrequency Ablation in Women With Invasive Breast Cancer (NCT00373152)Masonic Cancer Center, University of Minnesota2005-03-01
Donor Peripheral Stem Cell Transplant in Treating Patients With Relapsed Acute Myeloid Leukemia (NCT00274846)Masonic Cancer Center, University of Minnesota2005-03-01
Topotecan, Cisplatin, and Radiation Therapy in Treating Patients With Advanced Cervical Cancer (NCT00287911)Masonic Cancer Center, University of Minnesota2005-02-01
Donor Natural Killer Cells and Aldesleukin in Treating Patients w/High Risk AML Undergoing Donor Stem Cell Transplant (NCT00303667)Masonic Cancer Center, University of Minnesota2005-01-01
Chemoradiation in Locally Advanced Pancreatic Cancer (NCT00262951)Masonic Cancer Center, University of Minnesota2005-01-01
Mitomycin as a Hyperthermic Peritoneal Perfusion in Treating Patients With Malignant Ascites (NCT00265863)Masonic Cancer Center, University of Minnesota2004-08-01
Topotecan in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer (NCT00287859)Masonic Cancer Center, University of Minnesota2004-08-01
Autologous Transplant for Multiple Myeloma (NCT00177047)Masonic Cancer Center, University of Minnesota2004-04-20
Docetaxel in Treating Patients With Refractory or Recurrent Advanced Gynecologic Cancer (NCT00287885)Masonic Cancer Center, University of Minnesota2004-03-01
Stem Cell Transplantation for Fanconi Anemia (NCT00167206)Masonic Cancer Center, University of Minnesota2004-03-01
Stem Cell Transplant w/Laronidase for Hurler (NCT00176891)Masonic Cancer Center, University of Minnesota2004-03-01
Post Transplant Donor Lymphocyte Infusion (NCT00167180)Masonic Cancer Center, University of Minnesota2004-01-01
Safety Study of an Immune Response Modifier in Patients With Refractory Solid Organ Tumors (NCT00095160)Masonic Cancer Center, University of Minnesota2003-10-01
CpG 7909 in Treating Patients Who Have Undergone Autologous Stem Cell Transplant (NCT00369291)Masonic Cancer Center, University of Minnesota2003-09-01
Bronchial Artery Infusion of Gemcitabine in Treating Patients With Recurrent or Progressive Non-Small Cell Lung Cancer (NCT00619021)Masonic Cancer Center, University of Minnesota2003-01-01
Internal Radiation Therapy After Lumpectomy in Treating Women With Ductal Carcinoma in Situ (NCT00290654)Masonic Cancer Center, University of Minnesota2002-12-01
Stem Cell Transplant for Immunologic or Histiocytic Disorders (NCT00176865)Masonic Cancer Center, University of Minnesota2002-08-01
Vaccination With Tetanus and KLH to Assess Immune Responses. (NCT00000105)Masonic Cancer Center, University of Minnesota2002-07-01
Stem Cell Transplant for Hemoglobinopathy (NCT00176852)Masonic Cancer Center, University of Minnesota2002-06-01
Carboplatin, Gemcitabine, and Thalidomide in Patients Undergoing Surgery for Stage II or III Non-Small Cell Lung Cancer (NCT00281827)Masonic Cancer Center, University of Minnesota2002-05-01
Allogeneic Bone Marrow Transplantation Using Less Intensive Therapy (NCT00303719)Masonic Cancer Center, University of Minnesota2002-03-26
Hematopoietic Stem Cell Transplantation in High Risk Patients With Fanconi Anemia (NCT00258427)Masonic Cancer Center, University of Minnesota2002-03-26
Stem Cell Transplant for Hematological Malignancy (NCT00176930)Masonic Cancer Center, University of Minnesota2001-10-01
Chemotherapy and Total-Body Irradiation Followed by Donor Umbilical Cord Blood Transplant, Cyclosporine, and Mycophenolate Mofetil in Treating Patients With Hematologic Cancer (NCT00290641)Masonic Cancer Center, University of Minnesota2001-04-01
T-Cell Depletion and Stem Cell Transplant for Immune Deficiencies and Histiocytic Disorders (NCT00176826)Masonic Cancer Center, University of Minnesota2000-09-01
Filgrastim and Chemotherapy Followed by Peripheral Stem Cell Transplant in Treating Patients With Hodgkin's Lymphoma or Non-Hodgkin's Lymphoma (NCT00005985)Masonic Cancer Center, University of Minnesota2000-08-01
Chemotherapy, Filgrastim and Peripheral Stem Cell Transplantation in Patients With Chronic Myelogenous Leukemia (NCT00005986)Masonic Cancer Center, University of Minnesota2000-08-01
Cyclophosphamide and Filgrastim Followed By SCT in Patients With Chronic or Accelerated Phase Myelogenous Leukemia (NCT00005984)Masonic Cancer Center, University of Minnesota2000-08-01
Filgrastim Compared With Sargramostim Plus Chemotherapy, Peripheral Stem Cell Transplantation, and Interferon Alfa in Treating Patients With Multiple Myeloma (NCT00005987)Masonic Cancer Center, University of Minnesota2000-08-01
Stem Cell Transplantation for Hematological Malignancies (NCT00176839)Masonic Cancer Center, University of Minnesota2000-06-07
Combination Chemotherapy and Total-Body Irradiation Before Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer, Metastatic Breast Cancer, or Kidney Cancer (NCT00365287)Masonic Cancer Center, University of Minnesota2000-06-01
Stem Cell Transplant for Bone Marrow Failure Syndromes (NCT00176878)Masonic Cancer Center, University of Minnesota2000-06-01
Cytoxan, Fludara, and Antithymocyte Globulin Conditioning Followed By Stem Cell Transplant in Treating Fanconi Anemia (NCT00630253)Masonic Cancer Center, University of Minnesota2000-02-17
Peripheral Stem Cell Transplantation With Specially Treated Stem Cells in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease (NCT00005998)Masonic Cancer Center, University of Minnesota2000-01-01
Stem Cell Transplant for Juvenile Myelomonocytic Leukemia (JMML) (NCT00167219)Masonic Cancer Center, University of Minnesota1999-11-18
Donor Stem Cell Transplant in Treating Patients With Previously Treated Lymphoma, Multiple Myeloma, or Chronic Lymphocytic Leukemia (NCT00612716)Masonic Cancer Center, University of Minnesota1999-10-06
Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer (NCT00290628)Masonic Cancer Center, University of Minnesota1999-10-01
Cytosine Arabinoside and Mitoxantrone for Patients With Juvenile Myelomonocytic Leukemia Receiving Repeat Stem Cell Transplantation (NCT00609739)Masonic Cancer Center, University of Minnesota1999-06-01
Biological Therapies Following Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Advanced Breast Cancer (NCT00005993)Masonic Cancer Center, University of Minnesota1999-05-01
Stem Cell Transplantation for Hurler (NCT00176917)Masonic Cancer Center, University of Minnesota1999-05-01
Amifostine to Protect From Side Effects of PSCT in Treating Patients With Solid Tumors (NCT00003926)Masonic Cancer Center, University of Minnesota1998-11-01
Bone Marrow Transplantation in Treating Patients With Leukemia (NCT00006451)Masonic Cancer Center, University of Minnesota1996-04-01
Donor Lymphocyte Infusion (DLI) for Relapsed (Post Transplant) Leukemia (NCT00167167)Masonic Cancer Center, University of Minnesota1995-12-01
Stem Cell Transplant for Inborn Errors of Metabolism (NCT00176904)Masonic Cancer Center, University of Minnesota1995-01-01
Single Patient Use of Selinexor and Dexamethasone for a Patient With Multiple Myeloma (NCT03850704)Masonic Cancer Center, University of Minnesota
← Previous

Track Masonic Cancer Center, University of Minnesota automatically

Every clearance here is in the API, with alerts when new ones post.